FDA
-
-
-
-
-
-
-
RedHill Biopharma sets $6M private placement with warrant upside
-
-
-
-
-
-
-
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
-
-
-
-
-
-
-
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
-
-
-
-
-
-
-
Joint U.S. Commercialization of RedHill's Talicia® Commences
-
-
-
-
-
-
-
Cumberland Pharmaceuticals partners with RedHill for Talicia commercialization
-
-
-
-
-
-
-
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
-
-
-
-
-
-
-
Cumberland Pharmaceuticals (CPIX) Shares Phase 2 FIGHT DMD Trial Results
-
325,120 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

